Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Dementia: early-phase trial registry
79 of 202 indexed Dementia trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #48 of 28,707 conditions by registered trial count.
202 US clinical trials · 79 currently recruiting · #48 of 28,707 conditions by registered trial count
Dementia: 202 US clinical trials tracked, 79 recruiting.
Dementia is the subject of 202 registered US clinical trials on ClinicalTrials.gov, 79 of them currently open to new participants. 13 are in Phase 3-4 (later-stage) and 29 in Phase 1-2 (earlier-stage). The most active sponsor is University of Washington, running 8 of these trials.
Enrollment posture brief
Registry condition dementia
OPEN 79 | RECR 39% | LATE 13 | EARLY 29 | RANK #48 | SPON 8
Volume-matched condition peers
Nearest open-share peer: Advanced Non-Small-Cell Lung Cancer (39% recruiting · 23 trials)
Dementia lists 79 open slots (39% of 202 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Dementia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Dementia is recruiting above its size-band peers.
79 of 202 indexed trials (39.1%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Dementia trials is spread across many organizations.
University of Washington accounts for 8 of 202 trials (4%). 110 distinct sponsors appear on at least one study for this condition label.
-
Typical Dementia enrolment sits around 154 participants.
Median target enrolment is 154 among the 200 trials that report a genuine target (sentinel values excluded). 80 of those (40%) plan for fewer than 100 participants.
-
Dementia research is mostly interventional.
157 interventional and 45 observational studies make up this index (77.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
202 total, page 3 of 5
A Spanish-language Caregiver-Enabled Care Program
Ceresti Health
NCT06631144
Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) Diet in Stroke Patients Patients
Rush University Medical Center
NCT04337255
Supportive Care for Cognitively Impaired Patients and Families
Stanford University
NCT03881579
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (DIAN-TU)
Washington University School of Medicine
NCT05269394
Escitalopram for Agitation in Alzheimer's Disease
JHSPH Center for Clinical Trials
NCT03108846
Palliative Care for Patients With Dementia
Icahn School of Medicine at Mount Sinai
NCT05749146
Life's End Benefits of cannaBidiol and tetrahYdrocannabinol
University of Southern California
NCT05644262
Plasma Hydrogen Sulfide as a Biomarker for Alzheimer's Disease and Related Dementias
Louisiana State University Health Sciences Center Shreveport
NCT05060848
Developing a Communication Intervention for People With Memory Challenges and Their Care Partners
Weill Medical College of Cornell University
NCT05143255
Remote Game-based Exercise Program for Cognitive and Motor Function Improvement
University of California, Los Angeles
NCT05235113
Preventing Medication Mismanagement in People Living with Dementia Through Automated Medication Dispensing with Facial Recognition and Video Observation
HiDO Technologies
NCT06691256
Safety and Modulation of ABCC9 Pathways by Nicorandil for the Treatment of Hippocampal Sclerosis of Aging
Gregory Jicha, MD, PhD
NCT04120766
Multi-Center Study of Sensory Stimulation to Improve Brain Function
Cognito Therapeutics
NCT03556280
Efficacy of Caregiver Training Program in Enhancing Caregiver and Patient Outcomes
MapHabit
NCT05527405
DIAN-TU Amyloid Removal Trial (ART) in Dominantly Inherited Alzheimer's Disease
Washington University School of Medicine
NCT06384573
Sirtuin-NAD Activator in Alzheimer's Disease
Brigham and Women's Hospital
NCT05040321
Increasing Engagement and Positive Emotional Behavior of Older Adults With Mild-Moderate Dementia With the Use of Motion-Based Technology and Meaningful Activities
Midwestern University
NCT07209124
The Effect of De-Prescribing Antipsychotics on Health and Quality of Life for People With Dementia
Columbia University
NCT05172687
Aligning Patient Preferences: a Role Offering Alzheimer's Patients, Caregivers, and Healthcare Providers Education and Support
Indiana University
NCT03323502
Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) Study
American College of Radiology
NCT02420756
Genetic Studies in Familial Dementia
University of Miami
NCT04680013
Ginkgo Biloba Prevention Trial in Older Individuals
National Center for Complementary and Integrative Health (NCCIH)
NCT00010803
Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1)
University of Washington
NCT04281784
D-CARE - The Dementia Care Study: A Pragmatic Clinical Trial of Health System-Based Versus Community-Based Dementia Care
University of California, Los Angeles
NCT03786471
Aging Brain Care Virtual Program
Indiana University
NCT06245499
MIND-ICU Study: Delirium and Dementia in Veterans Surviving ICU Care
VA Office of Research and Development
NCT00400062
Pragmatic Use of PAIN-Advanced Dementia Scale in Emergency Departments
University of Chicago
NCT06370572
Diagnosis and Natural History Study of Patients With Neurological Conditions
National Institute of Neurological Disorders and Stroke (NINDS)
NCT00001549
Multidisciplinary Inpatient Palliative Care Intervention
Kaiser Permanente
NCT00325611
Reducing Disabilities in Alzheimer's Disease (RDAD) Translation in Area Agencies on Aging (AAAs)
University of Washington
NCT01708304
Rural Dementia Caregiver Project
University of California, San Francisco
NCT04428112
fMRI of Vulnerable Brain Regions in Persons at Risk for Alzheimer's Disease
University of Wisconsin, Madison
NCT00478491
Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD)
Teva Branded Pharmaceutical Products R&D
NCT00104273
Quality Improvement PrecivityAD Clinician Survey (QUIP I)
C2N Diagnostics
NCT05477056
Enhanced Quality in Primary Care for Elders With Diabetes and Dementia
NYU Langone Health
NCT03723707
Comprehensive Home-based Dementia Care Coordination for Medicare-Medicaid Dual Eligibles in Maryland
Johns Hopkins University
NCT02395731
Goals of Care: A Nursing Home Trial of Decision Support for Advanced Dementia
University of North Carolina, Chapel Hill
NCT01565642
MIND: Care Coordination for Community-living Person With Dementia
Johns Hopkins University
NCT02396082
Home Safety Clinical Trial for Alzheimer's Disease
US Department of Veterans Affairs
NCT00459355
Accelerated Non-Atherosclerotic Brain Arterial Aging Relationship to Alzheimer's Disease
Jose Gutierrez, MD, MPH
NCT04510168
LifeBio Memory Digital Reminiscence Platform
Benjamin Rose Institute on Aging
NCT04769466
Efficacy and Safety of Aricept in the Treatment of Severe Alzheimer's Disease
Eisai
NCT00096473
Care Management for Patients With Alzheimer Disease and Their Family Caregivers
Agency for Healthcare Research and Quality (AHRQ)
NCT00246896
Family Caregiver Online Survey (Dementia and Swallowing Difficulties)
University of Oregon
NCT06471660
In-Home Technology for Caregivers of People With Dementia and Mild Cognitive Impairment
University of California, Berkeley
NCT04206670
Posterior Cingulate Function in Persons With Risk Factors for Alzheimer's Disease
University of Wisconsin, Madison
NCT00478166
Supporting Family Caregivers With Technology for Dementia Home Care
University of Kansas Medical Center
NCT02483520
Technology and Family Thriving Study
University of California, Santa Barbara
NCT05150990
A Relational Research Recruitment and Engagement Intervention for Cognitive Aging Research
University of Wisconsin, Madison
NCT05444244
Life Enhancing Activities for Family Caregivers
University of California, San Francisco
NCT01825681
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 10 |
| Phase 2 | 19 |
| Phase 3 | 10 |
| Phase 4 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Dementia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Dementia trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Dementia page
202 registered trials, 79 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 79 Dementia trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of Washington sponsors the most Dementia trials on record, review their full trial history before evaluating a specific study. See University of Washington's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Dementia condition card totals 202 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.